During a Case-Based Roundtable® event, Lori J. Wirth, discussed the SELECT trial and the role of multikinase inhibitors in ...

Following the clearance of an investigational new drug application from the FDA, a phase 1 trial will examine the novel ...

Neal Shore, MD, FACS, discussed a study on survival outcomes in metastatic castration-sensitive prostate cancer comparing ...

Mass spectrometry and machine learning show promise for early cancer detection and prognosis by analyzing metabolic signatures.